- Technology evaluation: C242-DM1, ImmunoGen Inc. Smith, S. Curr. Opin. Mol. Ther. (2001)
- Technology evaluation: SGN-15, Seattle Genetics Inc. Smith, S. Curr. Opin. Mol. Ther. (2001)
- SGN-10. Seattle Genetics. Smith, S.V. Curr. Opin. Investig. Drugs (2001)